Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

SPRAVATO® (esketamine)

Medical Information

+ Save link

SPRAVATO Monotherapy Trial in Treatment-Resistant Depression Slide Deck

Last Updated: 04/07/2025

SUMMARY

The following SPRAVATO Monotherapy Trial in Treatment-Resistant Depression Slide deck is being provided to you in response to your unsolicited request.

Monotherapy Trial in treatment-resistant depression slide deck

These slides are not intended as an endorsement or promotion of any usage not contained in the SPRAVATO Full Prescribing Information.¹

An electronic copy of the slide deck may be accessed by clicking the hyperlink provided below. The deck is provided as a locked file and the content is not intended for modification.

https://www.jnjmedicalconnect.com/media/attestation/documents/0/spravato-monotherapy-trial-in-treatment-resistant-depression-slide-deck-pdf.pdf

References

Show

1	SPRAVATO (esketamine) nasal spray [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf